Mylan: basic facts



Political Donations and Lobbying, USA

IPR Disputes

FTC Price Fixing Case Against Mylan

The Federal Tade Commission accused Mylan and other companies in 1998 of orchestrating an illegal price increase that exceeded 2,000 percent for the generic drugs lorazepam and clorazepate, both used to treat Alzheimer’s disease and anxiety.

Contact Information

Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> Pharmaceutical Firms